Paper · 41008530
Beneficial Effects of Different Types of Exercise on Diabetic Cardiomyopathy.
Ma X and 8 others. Biomolecules, 2025. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Beneficial Effects of Different Types of Exercise on Diabetic Cardiomyopathy. Papers, record 41008530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008530
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Cardiomyopathies | Major topic |
| Physical Conditioning, Animal | Major topic |
| Animals | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Diabetes Mellitus, Experimental | |
| Myocardium | |
| Signal Transduction | |
| Myocytes, Cardiac | |
| Fibrosis | |
| Diabetes Mellitus, Type 2 | |
| Diet, High-Fat | |
| Cytokines | |
| Resistance Training | |
| High-Intensity Interval Training |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 32371185 | the National Natural Science Foundation of China | PubMed | PubMed | ||
| No | the Shanghai Oriental Talents Program (Youth Project) | PubMed | PubMed | ||
| 23010504200 | the Shanghai Science and Technology Plan Project | PubMed | PubMed | ||
| 2025KF002 | the Key Lab of Exercise and Health Sciences of Ministry of Education (Shanghai University of Sport) | PubMed | PubMed | ||
| NO. 11DZ2261100 | the Shanghai Key Lab of Human Performance (Shanghai University of Sport) | PubMed | PubMed | ||
| YJSCX-2025-012 | the Research and Innovation Grant for Graduate Students (Shanghai University of Sport) | YJSCX202501 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,909,160 | Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35909160 | PubMed |
| 2 | 36,568,097 | Diabetic cardiomyopathy: Clinical phenotype and practice. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36568097 | PubMed |
| 3 | 39,250,437 | Swimming alleviates myocardial fibrosis of type II diabetic rats through activating miR-34a-mediated SIRT1/PGC-1α/FNDC5 signal pathway. | PLoS One | 2024 | https://conductscience.org/library/papers/39250437 | PubMed |
| 4 | 38,329,809 | TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities. | Expert Opin Ther Targets | 2024 | https://conductscience.org/library/papers/38329809 | PubMed |
| 5 | 32,922,365 | High-Intensity Interval Training Restores Glycolipid Metabolism and Mitochondrial Function in Skeletal Muscle of Mice With Type 2 Diabetes. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32922365 | PubMed |
| 6 | 38,698,281 | Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. | Nat Metab | 2024 | https://conductscience.org/library/papers/38698281 | PubMed |
| 7 | 36,675,183 | ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675183 | PubMed |
| 8 | 29,032,504 | Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts. | Pflugers Arch | 2018 | https://conductscience.org/library/papers/29032504 | PubMed |
| 9 | 25,136,835 | NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. | PLoS One | 2014 | https://conductscience.org/library/papers/25136835 | PubMed |
| 10 | 35,235,096 | Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/35235096 | PubMed |
1 to 10 of 66
See all 66 referencesCited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,963,201 | Exercise-Based Management of Diabetic Cardiomyopathy: Preclinical Mechanisms, Clinical Evidence, and Translational Strategies. | J Diabetes | 2026 | https://conductscience.org/library/papers/42963201 | PubMed |
| 42,955,468 | Combined crocin and treadmill exercise regulate cardiac MicroRNA-23b, nuclear factor Erythroid 2-related factor 2, and tumor necrosis factor-alpha in experimental type 2 diabetes mellitus. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42955468 | PubMed |
| 42,942,053 | Exercise-Mediated Regulation of Ferroptosis in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942053 | PubMed |
| 42,934,109 | [Aerobic exercise improves metabolic disorders and multi-organ damage in diabetic rats by activating the Sirt1/Creb1/Ppargc1a axis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/42934109 | PubMed |
| 42,757,104 | Role of the cGAS-STING signaling pathway in diabetes mellitus and its complications: from mechanisms to therapeutics. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42757104 | PubMed |
| 42,198,977 | [Melatonin alleviates cardiomyocyte necroptosis in diabetic mice by inhibiting the STING signaling pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/42198977 | PubMed |
| 41,832,545 | Exercise modulates redox homeostasis in cardiovascular and metabolic diseases: from bench to clinic. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41832545 | PubMed |
| 41,704,821 | Mitochondria: the central hub linking exercise to enhanced cardiac function. | Front Physiol | 2026 | https://conductscience.org/library/papers/41704821 | PubMed |
| 41,695,095 | Aerobic exercise inhibits oxidative stress and improves diabetic cardiomyopathy in rats by activating the PROC/PAR1/Nrf2/HO-1 signaling pathway. | Front Physiol | 2026 | https://conductscience.org/library/papers/41695095 | PubMed |
| 41,594,656 | BDH1 Mediates Aerobic Exercise-Induced Improvement in Skeletal Muscle Metabolic Remodeling in Type 2 Diabetes Mellitus. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594656 | PubMed |
1 to 10 of 11
See all 11 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41008530
GET https://conductscience.org/api/papers/v1/41008530/references?page=2